The Effectiveness of a Lung Health Promotion Program Based on the 5A Self

Status Active, not recruiting

Clinical Trial Summary

This research will be conducted to examine the effect of the lung health promotion program based on the 5A self-management support model on some physiological parameters, Physical Activity Scale in the Elderly score, sleep quality, health status perception and vaccination status of adults aged 65 and over. The research will be carried out as a randomized controlled study with a parallel design. We estimate that the respiratory functions of the elderly will improve, their physical activity levels will increase, immunization against common infectious diseases will increase and people's health perceptions will improve. with the lung health promotion program based on the 5A self-management support model.

Clinical Trial Description

The population of the research consisted of 312 individuals aged 60 and over living in an elderly care and rehabilitation center. In the sample calculation of the research, taking into account the GPower 3.1.9.7 program and the results of similar studies in the literature, it was calculated that it would be sufficient to include a total of 42 individuals, 21 elderly individuals in each group, with a margin of error of 0.05 and a test power of 80%. Considering that there may be losses during the process in such studies, 5% of the sample number (2.1~2 people) was added to the study. The study was planned to include 22 elderly individuals in the intervention group and 22 elderly individuals in the control group. A program to improve lung health will be applied to the elderly in the experimental group. Within the scope of the research, participants; They will do diaphragmatic breathing exercises and pursed lip breathing exercises 2 days a week for 8 weeks. Participants will be asked to walk for 20-30 minutes every day for eight weeks. Monitoring will be done weekly. Participants will be counseled about infectious diseases, modes of transmission and the importance of vaccination, and will be advised to receive influenza and pneumococcal vaccines recommended for this age group. The 5A model guide will be used regarding behavioral change towards physical activity and vaccination. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06185842
Study type	Interventional
Source	Selcuk University
Contact
Status	Active, not recruiting
Phase	N/A
Start date	November 24, 2023
Completion date	February 29, 2024

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT03572335` - Systems Biology of Diffusion Impairment in Human Immunodeficiency Virus (HIV)
Recruiting	`NCT06088485` - The Effect of Bone Mineral Density in Patients With Adult Cystic Fibrosis
Terminated	`NCT03309358` - A Study of the Safety and Tolerability of Inhaled SNSP113 in Healthy Subjects and Subjects With Stable Cystic Fibrosis	Phase 1
Active, not recruiting	`NCT02504697` - DECAMP-2: Screening of Patients With Early Stage Lung Cancer or at High Risk for Developing Lung Cancer
Completed	`NCT01443845` - Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS)	Phase 4
Terminated	`NCT00524095` - Bronchiectasis in Chronic Obstructive Pulmonary Disease (COPD) Patients: Role of Prophylaxis	Phase 2
Completed	`NCT00210249` - Development of an Evaluation Method of Elderly Condition in Patient Receiving Chemotherapy Treatment
Completed	`NCT00023114` - p450 Mediated Lung Toxicity	N/A
Recruiting	`NCT06056882` - Simultaneous CLE Guided Crybiopsy in Patients With Pulmonary Nodules
Completed	`NCT03994848` - Incentive Spirometry Prehabilitation Study	N/A
Completed	`NCT00366509` - Role of Helicobacter Pylori and Its Toxins in Lung and Digestive System Diseases
Withdrawn	`NCT05100160` - Gabapentin for the Reduction of Opiate Use Following Pulmonary Resection (GROUP Trial)	Phase 3
Completed	`NCT03229473` - Fall Risk Assessment in COPD
Recruiting	`NCT04767074` - A Non-pharmacological Cough Control Therapy	N/A
Not yet recruiting	`NCT03899298` - Safety and Clinical Outcomes With Amniotic and Umbilical Cord Tissue Therapy for Numerous Medical Conditions	Phase 1
Completed	`NCT04996693` - On Dose Efficiency of Modern CT-scanners in Chest Scans	N/A
Recruiting	`NCT04996173` - Cryospray Therapy Versus Standard of Care for Benign Airway Stenosis (CryoStasis)	N/A
Completed	`NCT04601545` - The Virtual Reality Therapy as a Pulmonary Rehabilitation Supporting Method	N/A
Recruiting	`NCT03937583` - Screening for Cancer in Patients With Unprovoked VTE	Phase 4
Recruiting	`NCT02862418` - Imaging of Lungs With a New Type of Magnetic Resonance Imaging (MRI) Called UTE (Ultrashort Echo Time)

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

The Effectiveness of a Lung Health Promotion Program Based on the 5A Self Management Support Model.

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms